#BANKINDIA #IDEA #JMFINANCIL #RELIANCE #SBIN
#BANKINDIA #HDFCBANK #ICICIBANK #IGL #INDUSINDBK
#BANKINDIA #SBIN #UNIONBANK
#BANDHANBNK #BANKINDIA #ICICIBANK #YESBANK
#BANKINDIA #ICICIBANK #INDUSINDBK
BANK OF INDIA: Q1 SL NET PROFIT 7.2B RUPEES VS 8.44B (YOY); 2.5B (QOQ)
GNPA: 13.51% VS 13.77%
NNPA: 3.35% VS 3.35%
Today's Cash Stocks in News...
🔥🔥🔥 (8th June)
Stock Research Yogi
COMPANY NAME RESULT DATE
#AMBALALSA - 04 Jun 2021
#ASAHISONG - 04 Jun 2021
#ATHARVENT - 04 Jun 2021
#BAJGLOB - 04 Jun 2021
#BALGOPAL - 04 Jun 2021
#BALKRISHNA - 04 Jun 2021
#BANKINDIA - 04 Jun 2021
#BHARATFORG - 04 Jun 2021
#BRAWN - 04 Jun 2021
#CHDCHEM - 04 Jun 2021
#FOODSIN - 04 Jun 2021
#GCCLINP - 04 Jun 2021
#GUFICBIO - 04 Jun 2021
#IOLCP - 04 Jun 2021
#JAICORPLTD - 04 Jun 2021
#JIGAR - 04 Jun 2021
#JUBLPHARMA - 04 Jun 2021
#KELENRG - 04 Jun 2021
#KRANTI - 04 Jun 2021
#MEGASTAR - 04 Jun 2021
#MOIL - 04 Jun 2021
#NBFOOT - 04 Jun 2021
#NIITLTD - 04 Jun 2021
#PAISALO - 04 Jun 2021
#PENIND - 04 Jun 2021
Stocks in the news
Aurobindo Pharma: The company reported a sharp rise in profit at Rs 2,946.3 crore in Q3FY21 against Rs 705.3 crore in Q3FY20, revenue rose to Rs 6,364.9 crore from Rs 5,895 crore YoY.
Bata India: The company reported lower profit at Rs 26.4 crore in Q3FY21 against Rs 118.2 crore in Q3FY20, revenue fell to Rs 615.6 crore from Rs 830.8 crore YoY.
Indraprastha Gas: The company reported a higher profit at Rs 381.8 crore in Q3FY21 against Rs 297.4 crore in Q3FY20, revenue declined to Rs 1,446.2 crore from Rs 1,664.2 crore YoY.
Bank of India: The Competition Commission of India approved acquisition of BOI AXA Invst Managers & BOI AXA Trustee Services by Bank of India.
Titan Company: The company reported lower standalone profit at Rs 419 crore in Q3FY21 against Rs 470 crore in Q3FY20, revenue rose to Rs 7,287 crore from Rs 6,206.2 crore YoY.
Magma Fincorp: Rising Sun Holdings, a company controlled by Mr. Adar Poonawalla, to acquire a controlling stake in Magma Fincorp, through a preferential allotment and open offer route.
#MAGMA #AUROPHARMA #TITAN #BANKINDIA #IGL
Just gonna update on a few of our open positions shared here.
#CDSL - Cdsl Bought 498 and 485 only laggard Cmp 471 Hold with revised Sl 455 (Shared Here)
#DHAMPURSUG - Dhampursugar Bought 154 hit high 166 yesterday cmp 160 (Shared Here)
#BANKINDIA - Bankindia did high 46.45 from 43.9 and 43 cmp 44.65 (Shared Here)
TITAN - Titan bought 1320-1340 retested Flag bo and now cmp 1327 Keep hold with sl 1290 (Shared Here)
Csbbank not activated (Shared Here)
#IDEA - Idea bought 9.35 did high of 10.75 near T1 11 Cmp 9.95 (Shared Here) Part Booked
#VARROC - Varroc made high 373 looks good for more cmp 366 from 340-330 (Shared Here) Part Booked
Hope i have covered majority of our positions. Overall yesterday from the looks of it shorts were trapped in 12900 12800 levels which means bulls have a slight upper hand now and likely to head to 13200-13400 levels gradually. All our positions except one despite volatility are in the money or at near cost. Keep Booking as per comfort and trail. See you all next week.
INDIAN GOVT IS SAID TO PRIVATISE BOI, IOB,UCO AND CENTRAL BANK: ET NOW SOURCE
#NIFTY50 #NIFTYBANK #BANKINDIA #UCOBANK #CENTRALBK
📊✅ POSITIONAL ✅📊
BUY ABOVE 52.50
TARGET PRICE:- PAID SERVICE
SL PRICE:- PAID SERVICE
TARGET AND SL FOR PAID SERVICE:- https://front.page/equity99
To merger listed Future cos with Self
FEL to issue 9 shares for every 10 shares in Future Consumer
FEL to issue 116 shares for every 10 shares in FLFL
10 shares of FRL to fetch 101 shares in FEL
Future Supply Chain 10 shares to get 131 shares in FEL
Reliance Ind-Future Ent Deal | Retail & wholesale undertaking to be transferred to Reliance Retail & Fashion Lifestyle & Logistics & warehousing undertaking is being transferred to Reliance Retail Ventures (RRVL)
*Banks to Watch 👇🏼on Monday* -- Since lenders are one of the biggest beneficiaries according to analysts
- Bank of India
- RBL Bank
- Axis Bank
#FEL #RELIANCE #BANKINDIA #RBLBANK #AXISBANK
#BANKINDIA #WOCKPHARMA #SBIN #KANSAINER
The stock price spiked 10 percent after the company entered into an agreement with the UK government to finish COVID-19 vaccines. The manufacturing will be undertaken at CP Pharmaceuticals, a subsidiary of Wockhardt based in Wrexham, North Wales.
The stock jumped 5 percent after the company received multiple orders across geographies, including USA, KSA and India, of approximately 106 KMT valuing close to Rs 1,000 crore. With these orders, the company's order book stands at 759 KMT valued at approximately Rs 6,200 crore after considering execution up to June 2020.
**Bank of India**
The stock price gained over 2 percent after the company reported Q1 net profit of Rs 843.6 crore in the quarter ended June 2020 against Rs 242.6 crore in the year ago period. Net Interest Income (NII) was down to Rs 3,481 crore versus Rs 3,485 crore. The Gross NPA was at 13.91% versus 14.78% (QoQ), reported CNBC-TV18.
**State Bank of India**
The stock price ended in the green after brokerages, including CLSA, Nomura and Kotak, recommended a buy call on the stock. The PSU bank reported a standalone profit of Rs 4,189.34 crore for the quarter ended June 2020, a growth of 81.2 percent over a year-ago period driven by stake sale in life insurance business. Provisions and lower non-interest income limited growth in profit. Net interest income, the difference between interest earned and interest expended, increased 16.1 percent to Rs 26,641.56 crore in June quarter compared to Rs 22,938.8 crore in year-ago period.
The shares jumped 5 percent after the company's net profit rose 383 percent to Rs 31.16 crore in the quarter ended March 2020 as against Rs 6.45 crore during the previous quarter ended March 2019.
Sales rose 104.41 percent to Rs 207.39 crore in the quarter ended March 2020 as against Rs 101.46 crore during the previous quarter ended March 2019. For the full year,net profit rose 182.52% to Rs 71.28 crore in the year ended March 2020 as against Rs 25.23 crore during the previous year ended March 2019.
Sales declined 54.57% to Rs 685.22 crore in the year ended March 2020 as against Rs 1508.23 crore during the previous year ended March 2019.
**Kansai Nerolac Paints**
The share price was up over 3 percent after the company's consolidated net profit went down 79.5 percent to Rs 29.6 crore against Rs 144.7 crore YoY.
Cons revenue fell 58.6 percent to Rs 639 crore against Rs 1,542.4 crore YoY.
Consolidated EBITDA was down 69.7 percent at Rs 77 crore against Rs 254 crore YoY.
Consolidated EBITDA margin stood at 12 percent against 16.4 percent YoY.
The stock was up over 3 percent on improving prospects of operating margins. The company's strict cost rationalisation measures and exit from subdued businesses are expected to give its margins a shot in the arm. The company reported weaker-than-expected June quarter earnings with revenue declining on a year-on-year basis, in both its key general staffing and human resource services segments.
6.50 (+5.4) 33000/- profit
TECH30 - OPTION CALL BUY 72.50 CE @ 3.60